Stephan von Hörsten Selected Research

Hypersensitivity (Allergy)

7/2008	Inhibition of CD26/dipeptidyl peptidase IV enhances CCL11/eotaxin-mediated recruitment of eosinophils in vivo.
3/2008	Postnatal life events affect the severity of asthmatic airway inflammation in the adult rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephan von Hörsten Research Topics

Disease

19	Huntington Disease (Huntington's Disease) 08/2021 - 08/2005
11	Inflammation (Inflammations) 12/2021 - 04/2006
7	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2021 - 08/2005
5	Parkinson Disease (Parkinson's Disease) 05/2021 - 03/2008
5	Alzheimer Disease (Alzheimer's Disease) 05/2021 - 08/2008
5	Asthma (Bronchial Asthma) 10/2019 - 06/2007
4	Neoplasms (Cancer) 01/2020 - 05/2002
4	Schizophrenia (Dementia Praecox) 01/2020 - 06/2016
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 08/2009 - 04/2002
3	Disease Progression 08/2021 - 08/2002
3	Amyloid Plaque 01/2020 - 08/2008
3	Multiple Sclerosis 08/2009 - 04/2002
2	Pneumonia (Pneumonitis) 10/2019 - 11/2014
2	Body Weight (Weight, Body) 09/2017 - 01/2009
2	Hypersensitivity (Allergy) 07/2008 - 03/2008
2	Periodontal Diseases (Periodontal Disease) 07/2006 - 08/2002
2	Septic Shock (Toxic Shock Syndrome) 11/2004 - 10/2004
2	Infections 01/2004 - 07/2002
2	Pain (Aches) 10/2003 - 07/2002
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022
1	Microvascular Rarefaction 03/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Multiple System Atrophy 01/2021
1	Synucleinopathies 01/2021
1	Dyskinesias (Dyskinesia) 12/2020
1	Myeloperoxidase Deficiency 01/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020
1	Bronchiolitis Obliterans Syndrome 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Skin Diseases (Skin Disease) 01/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020
1	Lung Injury 10/2019
1	Psychotic Disorders (Schizoaffective Disorder) 12/2018
1	Cognitive Dysfunction 01/2017
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2017
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 03/2015
1	Respiratory Hypersensitivity 10/2013
1	Breast Neoplasms (Breast Cancer) 03/2012
1	Prodromal Symptoms 01/2012
1	Hypogonadism (Hypergonadotropic Hypogonadism) 04/2011

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 12/2021 - 09/2003
8	Neuropeptide YIBA 01/2020 - 08/2002
7	polyglutamineIBA 01/2021 - 08/2005
6	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 12/2021 - 08/2002
5	Peptides (Polypeptides)IBA 01/2021 - 12/2006
5	CytokinesIBA 01/2020 - 08/2002
4	SynucleinsIBA 05/2021 - 11/2011
4	EnzymesIBA 05/2021 - 08/2010
4	LipopolysaccharidesIBA 10/2019 - 08/2002
3	CorticosteroneIBA 01/2021 - 04/2002
3	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 02/2008
3	Amyloid (Amyloid Fibrils)IBA 01/2019 - 09/2011
3	EndotoxinsIBA 01/2019 - 07/2002
3	Immunoglobulin E (IgE)IBA 11/2014 - 06/2007
3	OvalbuminIBA 11/2014 - 06/2007
2	glutaminyl-peptide cyclotransferaseIBA 01/2021 - 04/2011
2	alpha-SynucleinIBA 01/2021 - 03/2008
2	Antipsychotic Agents (Antipsychotics)IBA 01/2020 - 12/2018
2	neuropeptide Y5 receptorIBA 01/2020 - 08/2002
2	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020 - 10/2013
2	Protein AggregatesIBA 01/2019 - 10/2010
2	Amphetamine (Amfetamine)FDA LinkGeneric 12/2018 - 01/2017
2	Neurotransmitter Agents (Neurotransmitter)IBA 03/2015 - 11/2004
2	Biomarkers (Surrogate Marker)IBA 03/2015 - 11/2012
2	Drinking WaterIBA 10/2013 - 08/2010
2	Dopamine (Intropin)FDA LinkGeneric 04/2012 - 11/2011
2	Pharmaceutical PreparationsIBA 04/2011 - 07/2006
2	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 01/2011 - 08/2010
2	Adrenergic Agents (Adrenergic Drugs)IBA 12/2009 - 03/2006
2	AntigensIBA 06/2007 - 01/2004
2	salicylhydroxamic acid (SHAM)IBA 07/2006 - 05/2002
2	Coloring Agents (Dyes)IBA 09/2003 - 05/2002
2	Imipramine (Janimine)FDA LinkGeneric 07/2002 - 04/2002
2	Antidepressive Agents (Antidepressants)IBA 07/2002 - 04/2002
1	PotassiumIBA 01/2022
1	Alkaline PhosphataseIBA 01/2022
1	CalciumIBA 08/2021
1	TransglutaminasesIBA 08/2021
1	Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA 01/2021
1	Levodopa (L Dopa)FDA LinkGeneric 12/2020
1	Peroxidase (Myeloperoxidase)IBA 01/2020
1	Vasopressins (Vasopressin)IBA 01/2020
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2020
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020
1	Surface-Active Agents (Surfactants)IBA 10/2019
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 10/2019
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 01/2019
1	Pyridinolcarbamate (P23)IBA 09/2017
1	NeuropeptidesIBA 06/2016
1	Anti-Anxiety Agents (Anxiolytics)IBA 03/2015
1	isoleucyl-thiazolidideIBA 10/2013
1	AllergensIBA 10/2013
1	AerosolsIBA 10/2013
1	CollagenIBA 03/2012
1	Deoxyglucose (2 Deoxy D glucose)IBA 03/2012
1	LipidsIBA 01/2012

Therapy/Procedure

2	Transplantation 03/2021 - 07/2009
2	Therapeutics 01/2015 - 07/2010
1	Lenses 01/2022